Cargando…
Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
The prognostic significance of the width of the ulceration in primary melanomas remains unclear, and there is a relative paucity of data for lymphovascular invasion (LVI), microscopic satellitosis (MS), perineural invasion (PNI), and mitotic rate when compared with other pathological elements curren...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852363/ https://www.ncbi.nlm.nih.gov/pubmed/29464914 http://dx.doi.org/10.1002/cam4.1320 |
_version_ | 1783306556796829696 |
---|---|
author | Namikawa, Kenjiro Aung, Phyu P. Gershenwald, Jeffrey E. Milton, Denái R. Prieto, Victor G. |
author_facet | Namikawa, Kenjiro Aung, Phyu P. Gershenwald, Jeffrey E. Milton, Denái R. Prieto, Victor G. |
author_sort | Namikawa, Kenjiro |
collection | PubMed |
description | The prognostic significance of the width of the ulceration in primary melanomas remains unclear, and there is a relative paucity of data for lymphovascular invasion (LVI), microscopic satellitosis (MS), perineural invasion (PNI), and mitotic rate when compared with other pathological elements currently required for reporting. To evaluate the prognostic importance of the ulceration width and other important pathologic measurements, a single‐institutional retrospective study was conducted using records of cutaneous melanoma patients who underwent sentinel lymph node (SLN) biopsy at The University of Texas, MD Anderson Cancer Center between 2003 and 2008. We identified 1898 eligible patients with median tumor thickness of 1.25 mm and median follow‐up of 6.7 years. By multivariable analyses, the strongest risk factor for SLN positivity was high tumor thickness followed by the presence of LVI. The pathologic measures with the strongest influence on recurrence‐free survival (RFS) were tumor thickness and positive SLN status. Ulceration width and presence of MS were also significantly associated with RFS while PNI was not. Factors with the strongest influence on melanoma‐specific survival (MSS) were positive SLN status and mitotic rate. In conclusion, SLN biopsy should probably be offered if the primary tumor has LVI. MS is an adverse prognostic factor for RFS, but its influence on outcome is modest. Ulceration width predicts RFS but loses its independent prognostic significance for MSS when adjusting for currently used clinicopathological factors. In view of its impact on MSS, mitotic rate should be recorded for cutaneous invasive melanomas across all T categories. |
format | Online Article Text |
id | pubmed-5852363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58523632018-03-22 Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center Namikawa, Kenjiro Aung, Phyu P. Gershenwald, Jeffrey E. Milton, Denái R. Prieto, Victor G. Cancer Med Clinical Cancer Research The prognostic significance of the width of the ulceration in primary melanomas remains unclear, and there is a relative paucity of data for lymphovascular invasion (LVI), microscopic satellitosis (MS), perineural invasion (PNI), and mitotic rate when compared with other pathological elements currently required for reporting. To evaluate the prognostic importance of the ulceration width and other important pathologic measurements, a single‐institutional retrospective study was conducted using records of cutaneous melanoma patients who underwent sentinel lymph node (SLN) biopsy at The University of Texas, MD Anderson Cancer Center between 2003 and 2008. We identified 1898 eligible patients with median tumor thickness of 1.25 mm and median follow‐up of 6.7 years. By multivariable analyses, the strongest risk factor for SLN positivity was high tumor thickness followed by the presence of LVI. The pathologic measures with the strongest influence on recurrence‐free survival (RFS) were tumor thickness and positive SLN status. Ulceration width and presence of MS were also significantly associated with RFS while PNI was not. Factors with the strongest influence on melanoma‐specific survival (MSS) were positive SLN status and mitotic rate. In conclusion, SLN biopsy should probably be offered if the primary tumor has LVI. MS is an adverse prognostic factor for RFS, but its influence on outcome is modest. Ulceration width predicts RFS but loses its independent prognostic significance for MSS when adjusting for currently used clinicopathological factors. In view of its impact on MSS, mitotic rate should be recorded for cutaneous invasive melanomas across all T categories. John Wiley and Sons Inc. 2018-02-21 /pmc/articles/PMC5852363/ /pubmed/29464914 http://dx.doi.org/10.1002/cam4.1320 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Namikawa, Kenjiro Aung, Phyu P. Gershenwald, Jeffrey E. Milton, Denái R. Prieto, Victor G. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
title | Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
title_full | Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
title_fullStr | Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
title_full_unstemmed | Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
title_short | Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
title_sort | clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852363/ https://www.ncbi.nlm.nih.gov/pubmed/29464914 http://dx.doi.org/10.1002/cam4.1320 |
work_keys_str_mv | AT namikawakenjiro clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter AT aungphyup clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter AT gershenwaldjeffreye clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter AT miltondenair clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter AT prietovictorg clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter |